Serious protocol violations jeopardise Bharat Biotech's assessment of the...
Bharat Biotech
The US company made its decision after consulting with...
A mid-stage trial of the vaccine in South Africa,...
Two iterations of the information sheet don't discuss the...
"It is unlikely that the mutation 501Y would be...
Asked why it did not attend meetings called by...
The instruction effectively attempts to tip the scales of...












